How Peptidings Makes Money

Affiliate Disclosure & Editorial Policy

Running a peptide research site that refuses to oversell the evidence turns out to be a lot of work. The primary literature doesn’t summarize itself, the community claims require constant auditing against what studies actually show, and a glossary of 115 terms doesn’t write itself on enthusiasm alone.

Peptidings is funded through affiliate marketing. When you use one of the links on this site to visit a partner service and make a purchase or subscribe, we earn a commission. That’s it. No advertising, no sponsored content, no investor with opinions about what we should and shouldn’t say about their portfolio companies.

We think that’s a fair trade. You get free access to the most evidence-honest peptide reference on the internet. We get to keep the lights on. The model only works if you trust us, which means we have a strong structural interest in not compromising the thing that makes us worth reading.

What Our Affiliate Relationships Do Not Do

This is the part that actually matters. The following rules are not aspirational — they are the operating policy:

• Affiliate partners are never named in the editorial body of compound articles. The mechanism section of an argireline article does not mention a skincare brand. The evidence table for semaglutide does not mention a weight loss clinic. Editorial content and commercial content are in different sections of the page, separated by a visible divider.
• Commercial relationships never influence evidence tier classifications. A compound is Pilot Data or Preclinical because the literature says so — not because a partner would prefer a more favorable characterization.
• If our research contradicts a partner’s marketing claims, we say so. If a partner says their product is “clinically proven” and our evidence review says the evidence base is limited, our article says the evidence base is limited. The affiliate link still appears in the resources section. The honest assessment still appears in the article.
• Coverage decisions are driven by research interest and reader demand, not by partner preferences. We cover the compounds the community is most asking about. Partners don’t get to request articles or steer editorial priorities.

FTC Disclosure

In compliance with the FTC’s Endorsement Guides (16 C.F.R. Part 255), Peptidings discloses all material connections with commercial partners. Specifically:

• Every page on this site that contains affiliate links displays a disclosure notice.
• All affiliate links are marked with rel="nofollow sponsored" in the HTML.
• Compensation is received in the form of commissions or referral fees when a reader purchases or subscribes through a tracked link. We do not receive payment for editorial coverage, article placement, or favorable evidence assessments.
• This disclosure page lists all currently active affiliate relationships and is updated whenever partnerships change.

Current Affiliate Partners

This list is generated automatically from our partner database and reflects current active relationships only. Partners that have been deactivated do not appear here.

Questions About a Specific Partnership

If you have a question about a specific affiliate relationship — whether a recommendation reflects a commercial arrangement, why a particular partner was selected, or anything else about how this program works — write to us at affiliates@peptidings.com. We’ll respond directly.